These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15507395)

  • 1. Characterization of virus-specific CD8(+) effector T cells in the course of HIV-1 infection: longitudinal analyses in slow and rapid progressors.
    Jansen CA; Piriou E; Bronke C; Vingerhoed J; Kostense S; van Baarle D; Miedema F
    Clin Immunol; 2004 Dec; 113(3):299-309. PubMed ID: 15507395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
    Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D
    J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression to CMV end-organ disease in HIV-1-infected individuals despite abundance of highly differentiated CMV-specific CD8+ T-cells.
    Bronke C; Westerlaken GH; Miedema F; Tesselaar K; van Baarle D
    Immunol Lett; 2005 Mar; 97(2):215-24. PubMed ID: 15752561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low levels of perforin expression in CD8+ T lymphocyte granules in lymphoid tissue during acute human immunodeficiency virus type 1 infection.
    Andersson J; Kinloch S; Sönnerborg A; Nilsson J; Fehniger TE; Spetz AL; Behbahani H; Goh LE; McDade H; Gazzard B; Stellbrink H; Cooper D; Perrin L
    J Infect Dis; 2002 May; 185(9):1355-8. PubMed ID: 12001057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8 T cell effector maturation in HIV-1-infected children.
    Jordan KA; Furlan SN; Gonzalez VD; Karlsson AC; Quigley MF; Deeks SG; Rosenberg MG; Nixon DF; Sandberg JK
    Virology; 2006 Mar; 347(1):117-26. PubMed ID: 16406047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detailed kinetics of EBV-specific CD4+ and CD8+ T cells during primary EBV infection in a kidney transplant patient.
    Piriou ER; van Dort K; Weel JF; Bemelman FJ; Gamadia LE; van Oers MH; van Baarle D
    Clin Immunol; 2006 Apr; 119(1):16-20. PubMed ID: 16386961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors.
    Migueles SA; Laborico AC; Shupert WL; Sabbaghian MS; Rabin R; Hallahan CW; Van Baarle D; Kostense S; Miedema F; McLaughlin M; Ehler L; Metcalf J; Liu S; Connors M
    Nat Immunol; 2002 Nov; 3(11):1061-8. PubMed ID: 12368910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8+ T cell responses to human immunodeficiency viruses type 2 (HIV-2) and type 1 (HIV-1) gag proteins are distinguishable by magnitude and breadth but not cellular phenotype.
    Gillespie GM; Pinheiro S; Sayeid-Al-Jamee M; Alabi A; Kaye S; Sabally S; Sarge-Njie R; Njai H; Joof K; Jaye A; Whittle H; Rowland-Jones S; Dorrell L
    Eur J Immunol; 2005 May; 35(5):1445-53. PubMed ID: 15832290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the composition of circulating CD8+ T cell subsets during acute epstein-barr and human immunodeficiency virus infections in humans.
    Roos MT; van Lier RA; Hamann D; Knol GJ; Verhoofstad I; van Baarle D; Miedema F; Schellekens PT
    J Infect Dis; 2000 Aug; 182(2):451-8. PubMed ID: 10915075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties of murine (CD8+)CD27- T cells.
    Baars PA; Sierro S; Arens R; Tesselaar K; Hooibrink B; Klenerman P; van Lier RA
    Eur J Immunol; 2005 Nov; 35(11):3131-41. PubMed ID: 16220536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High responsiveness of HLA-B57-restricted Gag-specific CD8+ T cells in vitro may contribute to the protective effect of HLA-B57 in HIV-infection.
    Jansen CA; Kostense S; Vandenberghe K; Nanlohy NM; De Cuyper IM; Piriou E; Manting EH; Miedema F; van Baarle D
    Eur J Immunol; 2005 Jan; 35(1):150-8. PubMed ID: 15593302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of CD8+ T lymphocytes in chronic HIV-1 subtype A infection in Rwandan women.
    Jiang Y; Karita E; Castor D; Jolly PE
    Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51 Suppl():OL737-43. PubMed ID: 16171573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus (CMV)-specific CD8+ T cells in individuals with HIV infection: correlation with protection from CMV disease.
    Stone SF; Price P; French MA
    J Antimicrob Chemother; 2006 Apr; 57(4):585-8. PubMed ID: 16504998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of changes in antigen level on CD38/PD-1 co-expression on HIV-specific CD8 T cells in chronic, untreated HIV-1 infection.
    Vollbrecht T; Brackmann H; Henrich N; Roeling J; Seybold U; Bogner JR; Goebel FD; Draenert R
    J Med Virol; 2010 Mar; 82(3):358-70. PubMed ID: 20087935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of CD4(+) T cells in human cytomegalovirus infection.
    Gamadia LE; Rentenaar RJ; van Lier RA; ten Berge IJ
    Hum Immunol; 2004 May; 65(5):486-92. PubMed ID: 15172448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8+ T cells from most HIV-1-infected patients, even when challenged with mature dendritic cells, lack functional recall memory to HIV gag but not other viruses.
    Arrode G; Finke JS; Zebroski H; Siegal FP; Steinman RM
    Eur J Immunol; 2005 Jan; 35(1):159-70. PubMed ID: 15580653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic CD4 T cells in viral hepatitis.
    Aslan N; Yurdaydin C; Wiegand J; Greten T; Ciner A; Meyer MF; Heiken H; Kuhlmann B; Kaiser T; Bozkaya H; Tillmann HL; Bozdayi AM; Manns MP; Wedemeyer H
    J Viral Hepat; 2006 Aug; 13(8):505-14. PubMed ID: 16901280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of human granzymes A, B, and K in natural killer cells and during CD8+ T cell differentiation in peripheral blood.
    Bratke K; Kuepper M; Bade B; Virchow JC; Luttmann W
    Eur J Immunol; 2005 Sep; 35(9):2608-16. PubMed ID: 16106370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulation of CD28 and CTLA-4 expression by CD4 T cells from previously immunodeficient HIV-infected patients with sustained virological responses to highly active antiretroviral therapy.
    Stone SF; Price P; French MA
    HIV Med; 2005 Jul; 6(4):278-83. PubMed ID: 16011533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous activation of viral antigen-specific memory CD4+ and CD8+ T-cells using mRNA-electroporated CD40-activated autologous B-cells.
    Van den Bosch GA; Van Gulck E; Ponsaerts P; Nijs G; Lenjou M; Apers L; Kint I; Heyndrickx L; Vanham G; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF
    J Immunother; 2006; 29(5):512-23. PubMed ID: 16971807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.